INTRODUCTION
Actin is the eukaryotic substrate for several clostridial ADPribosylating toxins Aktories and Just, 1990; Aktories et al., 1992) . It has been shown using protein chemistry that actin is ADP-ribosylated at Arg-177 (Vandekerckhove et al., 1987 (Vandekerckhove et al., , 1988 , a modification that inhibits actin polymerization (Aktories et al., 1986; Schering et al., 1988) and blocks G-actin ATPase activity (Geipel et al. 1989 . ADP-ribosylated actin interacts with the fast growing barbed ends of actin filaments in a capping-protein-like manner to inhibit polymerization of non-modified actin (Weigt et al., 1989; Wegner and Aktories, 1988) . Furthermore, recent studies indicate that the toxins ADP-ribosylate actin in complexes with gelsolin thereby altering the nucleation activity of the gelsolin-actin complex .
The family of actin-ADP-ribosylating toxins comprises Clostridium botulinum C2 toxin (Aktories et al., 1986) , Clostridium perfringens iota toxin Simpson et al., 1987) , Clostridium spiroforme toxin Simpson et al., 1989) and an ADP-ribosyltransferase produced by Clostridium difficile . All these toxins are binary in structure and consist of a binding component and a non-linked enzyme component . Clostridial toxins can be divided into two subclasses. The iotalike toxins (C. perfringens iota toxin, C. spiroforme toxin and C. dificile ADP-ribosyltransferase) are immunologically related and their binding components can replace each other. In contrast, C. botulinum C2 toxin exhibits no immunological cross-reactivity with the iota-like toxins and its binding component is not able to transfer the enzyme component of iota-like toxins into cells (Simpson et al., 1987 (Simpson et al., , 1989 .
Furthermore, C. botulinum C2 toxin and C. perfringens iota toxin differ in their actin substrate specificity. Whereas iota toxin ADP-ribosylates all actin isoforms studied so far Mauss et al., 1990 ), C2 toxin is not able to use vertebrate skeletal, cardiac or smooth-muscle a-actin as substrates (Aktories et al., 1986; Mauss -et al., 1990 ). Here we used Drosophila vivo was not ADP-ribosylated confirming Arg-177 as the ADPribose acceptor. Mutant LI 76M actin was modified by both toxins, indicating that amino acid 176 of actin does not define the substrate specificity of C. botulinum C2 toxin. Whereas the gene products of various C-terminal mutants of Act88F translated in vitro (E334K, V3391, E364K, G368E, R372H) were substrates for ADP-ribosylation by C. botulinum C2 toxin and by C. perfringens iota toxin, neither toxin modified the N-terminal 0-12 deletion mutant.
indirect-flight-muscle actin as a probe for muscle actin to investigate further the substrate specificity of both toxins. We show that Drosophila flight-muscle actin and arthrin (Ball et al., 1987) , a ubiquitin-modified actin, both serve as substrates for ADP-ribosylation by clostridial toxins. Furthermore, we report on the toxin-catalysed ADP-ribosylation of various actin mutants translated in vitro in reticulocyte lysate.
MATERIALS AND METHODS Materials C. botulinum C2 toxin (Ohishi et al., 1980) and C. perfringens iota toxin (Stiles and Wilkens, 1986) Purification of Drosophila Indirect-flignt-muscle-specific actin Indirect-flight-muscle myofibrils were prepared from homogenates of whole Drosophila using procedures slightly modified from those of Saide et al. (1989) . Actin was prepared from these myofibrils using a standard protocol for extraction of insect actin (Bullard et al., 1973) , with a heating step (Szilagyi and Lu, 1982) included during extraction of actin from acetone powder with ACEX buffer (10 mM Tris/HCl, pH 8.0, 0.5 mM ATP, 0.2 mM CaCl2, 1.0 mM dithiothreitol).
Preparation of Drosophila actin mutants The C-terminal mutants (E334K, V3391, E364K, G368E and R372H) were made by in vitro mutagenesis of the cloned Act88F gene (Drummond et al., 1991a) . The mutants L176M, R177Q and AO-12 were constructed by oligonucleotide-directed mutagenesis as described in Drummond et al. (1992) . Transcription and translation of wild-type and mutant actins was carried out in vitro as described by Drummond et al. (1991a) .
I To whom correspondence should be addressed. 409 1. Just and others ADP-riboyslation assay ADP-ribosylation of actin and arthrin purified from Drosophila indirect flight muscle was carried out essentially as described (Aktories et al., 1986; Schering et al., 1988; Just et al., 1990 ) in a medium containing 2 mM MgCl2, 1 mM EDTA, 1 mM dithiothreitol, 1 j#M NAD, 100 ,uM phenylmethanesulphonyl fluoride, 20,ug/ml leupeptin, 25 mM triethanolamine/HCl (pH 7.5) and 1-5 ,ug of actin and arthrin with 100 ng of iota toxin or 100 ng of C2 toxin in a total volume of 100 l, for 15 min at 37 'C. ADP-ribosylation of in vitro-translated actin was performed in the same buffer with 2,u1 of reticulocyte lysate (approx. 10 pg of actin) in a total volume of 10 ,ul.
Non-denaturing gel electrophoresis Non-denaturing gel electrophoresis was performed as described by Safer (1989) in a Bio-Rad mini-Protean II gel system. Samples were prepared as described by Drummond et al. (1991b) by adding 2,l of sample buffer to 10 ul of the ADP-ribosylation reaction mixture. After centrifugation for 15 min at 13 000 g, 5 ,Il of the supernatant was loaded on to the gel.
Two-dimensional pel electrophoreses
Two-dimensional gel electrophoresis was performed in Bio-Rad mini-Protean II two-dimensional cells by the method of O'Farrell (1975) .
Chemical stability of the ADP-ribose-protein bond
The chemical stability of the ADP-ribose bond was studied as described previously (Tsai et al., 1984; Mayer et al., 1988) . After the [32P]ADP-ribosylation of actin and arthrin, the reaction was terminated by the addition of 100 mM Hepes (pH 7.5) and 2 % SDS. Thereafter, the ADP-ribosylated proteins were treated with 0.5 M NaCl or 0.5 M hydroxylamine (pH 7.5) for 2 h at 37°C or with 1 mM HgCl2 for 30 min at 37 'C. The trichloroacetic acidprecipitated proteins were dissolved in sample buffer and used for SDS/PAGE (Laemmli, 1970) .
RESULTS
First we studied the ADP-ribosylation of purified indirect-flightmuscle actin by C. botulinum C2 toxin and C. perfringens iota toxin. Figure 1 (Bullard et al., 1985; Ball et al., 1987) . The actin preparation from Drosophila muscle contains more than one actin isoform (results not shown), although the predominant one is the flightmuscle-specific actin. From this, we cannot exclude the possibility that ADP-ribosylation of actin is only of non-flight-muscle actins. However, arthrin is specific for the indirect flight muscle (Bullard et al., 1985; Ball et al., 1987) . The observation that arthrin is ADP-ribosylated indicates that the indirect-flightmuscle-specific actin is a substrate for C2 toxin. This is confirmed by the ADP-ribosylation of actin expressed in vitro from indirectflight-muscle-specific Act88F gene (see below). Pretreatment of Drosophila actin with phalloidin, which decreases the critical concentration of actin polymerization (Cooper, 1987) , inhibited the ADP-ribosylation by both toxins. Figure 2 shows that increasing concentrations of phalloidin decreased the labelling of Drosophila actin and of arthrin.
Next, we studied the chemical stability ofthe ADP-ribose-actin linkage towards neutral hydroxylamine. As shown in Figure 3 The wild-type (anes 1-3) and mutant [Li 76M (lanes 4-6) and Rl 77Q (lanes 7-9)] actins were ADP-ribosylated by C. botulinum C2 toxin (lanes 3, 6 and 9) and C. perfringens iota toxin (lanes 2, 5 and 8) and subsequently separated by non-denaturing gel electrophoresis. The autoradiograph is shown. Lanes 1, 4 and 7 show controls.
treatment of ADP-ribosylated actin and arthrin for 2 h with 0.5 M hydroxylamine largely reduced the labelling, indicating that the ADP-ribose moiety is bound to arginine (Hsia et al., 1985; Aktories et al., 1988) . HgCl2 treatment, which cleaves the ADP-ribose-cysteine bond (Mayer et al., 1988) , had no effect. By using Drosophila indirect-flight-muscle actin mutants, we attempted to test two hypotheses. First, it has been claimed from the results of chemical analysis that Arg-177 is the residue that is ADP-ribosylated (Vandekerckhove et al., 1987 (Vandekerckhove et al., , 1988 . Second, it has been suggested that the substrate specificity of C. botulinum C2 toxin might be defined by the amino acid that precedes Argl77: it is leucine in all ,8/y non-muscle actins and methionine in a-actin isoforms. For this purpose, the R177Q and L176M mutants of the Act88F ffight-muscle gene were constructed and expressed in vitro in rabbit reticulocyte lysate. Subsequently, the mutant proteins were [32P]ADP-ribosylated by the toxins. However, analysis of the labelled proteins by SDS/PAGE was hampered by the fact that the reticulocyte lysate contained small amounts of endogenous rabbit cytoplasmic actin which was also substrate for ADP-ribosylation (results not shown). Therefore the newly expressed actin was labelled with [35S]methionine, then ADP-ribosylated in the presence of unlabelled NAD and the proteins were analysed by non-denaturing gel electrophoresis. Figure 4 shows that the ADP-ribosylation changed the migration behaviour of [35S]methionine-labelled wild-type actin which has leucine in position 176. A similar change in migration was observed for the L176M mutant actin after ADP-ribosylation by C. botulinum C2 toxin and C. perfringens iota toxin, indicating that the mutant actin was a substrate for both toxins. In contrast, no change in the migration of actin was observed when the R177Q mutant was ADP-ribosylated, indicating that neither C. botulinum C2 toxin nor C. perfringens iota toxin was able to ADP-ribosylate actin with glutamine at position 177. R177Q actin has a different mobility on the gels because of its different charge. These results were corroborated by using twodimensional analysis of the ADP-ribosylated actin. Figure 5 shows that the ADP-ribosylation of Drosophila wild-type actin did not cause major changes in the Mr of actin, but the pl was shifted to more acidic values. This also held true for the L176M mutant but not for the R177Q mutant of the Act88F gene product. We studied the ADP-ribosylation of the E334K, V339I, E364K, G368E and R372H actin mutants which have been shown to be antimorphic in vivo (Drummond et al., 1991a) . All of them were substrates for C. botulinum C2 and C.perfringens iota toxin (results not shown). A mutant actin that lacked the initial 12 amino acids at the N-terminus migrated much more slowly on the non-denaturing gel, which is most probably due to loss of acidic amino acids. However, neither C. botulinum C2 toxin nor C. perfringens iota toxin induced changes in the migration compared with controls, indicating that the 0-12 deletion mutant was not modified by ADP-ribosylation (results not shown). 
DISCUSSION
Here we report that Drosophila melanogaster indirect-flightmuscle actin was ADP-ribosylated by C. botulinum C2 toxin and C. perfringens iota toxin. This is the first demonstration of ADPribosylation by C2 toxin of a striated muscle actin isoform, although the amino acid sequence of Act88F actin is closer to that of vertebrate cytoplasmic than vertebrate muscle actins. Furthermore, arthrin, a ubiquitinated actin derivative (Bullard et al., 1985; Ball et al., 1987) . was also modified by the toxins. Arthrin is known to share most properties with actin; for example, it co-polymerizes with actin and binds myosin (Bullard et al., 1985; Ball et al., 1987) ADP-ribosylated actin, e.g. ,/y-actin (Aktories et al., 1986) or skeletal-muscle actin , cannot polymerize. Our findings that the ADP-ribosylation of actin and arthrin was inhibited by phalloidin, which induces actin polymerization, indicate that the polymerized forms of both proteins are no longer substrates for ADP-ribosylation. This observation agrees with former reports that mammalian G-actin but not F-actin is a substrate for ADP-ribosylation (Aktories et al., 1986; Schering et al., 1988) . Furthermore, the ADP-ribose-protein bonds of actin and of arthrin were sensitive towards hydroxylamine, a finding that indicates that arthrin is also ADP-ribosylated at an arginine, probably Arg-177 of actin Vandekerckhove et al., 1987 Vandekerckhove et al., , 1988 .
C. botulinum C2 toxin is characterized by a remarkable substrate specificity, because no oc-actin isoforms (skeletal, cardiac and smooth muscle) are modified by the toxin (Mauss et al., 1990) . In contrast, C. perfringens iota toxin ADP-ribosylates all actin isoforms studied so far. It has been suggested that the amino acid that precedes Arg-177, namely leucine in non-muscle actin and methionine in a-actin isoforms, defines the substrate specificity of C2 toxin (Vandekerckhove et al., 1988 ). Here we show that the Drosophila Act88F gene actin, a muscle actin isoform that possesses leucine in position 176, was ADPribosylated by C2 toxin. However, the L176M mutant of Act88F was still modified by C2 toxin, indicating that amino acid 176 does not define the substrate specificity for ADP-ribosylation. In contrast, the R177Q mutant was modified by neither toxin, a finding that is in agreement with the recent report that Arg-177 is the amino acid acceptor for ADP-ribosylation by C2 toxin and iota toxin. Several C-terminal actin mutants that have been shown to be antimorphic for flight in vivo (Drummond et al., 1991a) were studied, all of which were modified, suggesting that the amino acids Glu-334, Val-339, and Arg-372 are not crucial for ADP-ribosylation by the toxins. In contrast, the 0-12 deletion of actin was not modified by either toxin. This deletion includes part of the N-terminus of actin that is apparently important for bivalent cation and nucleotide binding (Kabsch et al., 1990) and therefore for the structural integrity of actin (Johannes and Gallwitz, 1991) . However, the AO-12 mutant still retains its ability to bind to profilin and DNAase I (Drummond et al., 1992) . Since it has been shown that the ADP-ribosylation of actin depends on the native structure of actin (e.g. treatment of actin with EGTA inhibits ADPribosylation), it is not clear whether the deletion of the mobile Nterminus of actin itself or gross changes in the overall actin structure of the 0-12 mutant are responsible for the loss of the ability of actin to serve as substrate for ADP-ribosylation by the toxins.
